| Neutralization of the SARS-CoV-2 omicron BA. 4/5 and BA. 2.12. 1 subvariants P Qu, J Faraone, JP Evans, X Zou, YM Zheng, C Carlin, JS Bednash, ... New England Journal of Medicine 386 (26), 2526-2528, 2022 | 172 | 2022 |
| Enhanced neutralization resistance of SARS-CoV-2 omicron subvariants BQ. 1, BQ. 1.1, BA. 4.6, BF. 7, and BA. 2.75. 2 P Qu, JP Evans, JN Faraone, YM Zheng, C Carlin, M Anghelina, ... Cell host & microbe 31 (1), 9-17. e3, 2023 | 170 | 2023 |
| Neutralization of SARS-CoV-2 Omicron sub-lineages BA. 1, BA. 1.1, and BA. 2 JP Evans, C Zeng, P Qu, J Faraone, YM Zheng, C Carlin, JS Bednash, ... Cell host & microbe 30 (8), 1093-1102. e3, 2022 | 116 | 2022 |
| Neutralizing antibody against SARS-CoV-2 spike in COVID-19 patients, health care workers, and convalescent plasma donors C Zeng, JP Evans, R Pearson, P Qu, YM Zheng, RT Robinson, ... JCI insight 5 (22), 2020 | 93 | 2020 |
| Neutralization and stability of SARS-CoV-2 Omicron variant C Zeng, JP Evans, P Qu, J Faraone, YM Zheng, C Carlin, JS Bednash, ... biorxiv, 2021 | 88 | 2021 |
| Enhanced evasion of neutralizing antibody response by Omicron XBB. 1.5, CH. 1.1, and CA. 3.1 variants P Qu, JN Faraone, JP Evans, YM Zheng, C Carlin, M Anghelina, ... Cell reports 42 (5), 2023 | 77 | 2023 |
| COVID-19 mRNA booster vaccines elicit strong protection against SARS-CoV-2 Omicron variant in patients with cancer C Zeng, JP Evans, K Chakravarthy, P Qu, S Reisinger, NJ Song, ... Cancer Cell 40 (2), 117-119, 2022 | 73 | 2022 |
| Evasion of neutralizing antibody responses by the SARS-CoV-2 BA. 2.75 variant P Qu, JP Evans, YM Zheng, C Carlin, LJ Saif, EM Oltz, K Xu, RJ Gumina, ... Cell host & microbe 30 (11), 1518-1526. e4, 2022 | 70 | 2022 |
| Durability of booster mRNA vaccine against SARS-CoV-2 BA. 2.12. 1, BA. 4, and BA. 5 subvariants P Qu, JN Faraone, JP Evans, YM Zheng, L Yu, Q Ma, C Carlin, G Lozanski, ... New England Journal of Medicine 387 (14), 1329-1331, 2022 | 69 | 2022 |
| Distinct neutralizing antibody escape of SARS-CoV-2 Omicron subvariants BQ. 1, BQ. 1.1, BA. 4.6, BF. 7 and BA. 2.75. 2 P Qu, JP Evans, J Faraone, YM Zheng, C Carlin, M Anghelina, P Stevens, ... Biorxiv, 2022 | 66 | 2022 |
| A nanoparticle-based hepatitis C virus vaccine with enhanced potency Y Yan, X Wang, P Lou, Z Hu, P Qu, D Li, Q Li, Y Xu, J Niu, Y He, J Zhong, ... The Journal of Infectious Diseases 221 (8), 1304-1314, 2020 | 60 | 2020 |
| Neutralization of SARS-CoV-2 variants of concern harboring Q677H C Zeng, JP Evans, JN Faraone, P Qu, YM Zheng, L Saif, EM Oltz, ... MBio 12 (5), 10.1128/mbio. 02510-21, 2021 | 40 | 2021 |
| Extraordinary evasion of neutralizing antibody response by Omicron XBB. 1.5, CH. 1.1 and CA. 3.1 variants P Qu, JN Faraone, JP Evans, YM Zheng, C Carlin, M Anghelina, ... BioRxiv, 2023 | 36 | 2023 |
| Insect cell-produced recombinant protein subunit vaccines protect against Zika virus infection P Qu, W Zhang, D Li, C Zhang, Q Liu, X Zhang, X Wang, W Dai, Y Xu, ... Antiviral Research 154, 97-103, 2018 | 33 | 2018 |
| Immune evasion and membrane fusion of SARS-CoV-2 XBB subvariants EG. 5.1 and XBB. 2.3 JN Faraone, P Qu, N Goodarzi, YM Zheng, C Carlin, LJ Saif, EM Oltz, ... Emerging Microbes & Infections 12 (2), 2270069, 2023 | 31 | 2023 |
| Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 Omicron BA. 2.86 and FLip variants P Qu, K Xu, JN Faraone, N Goodarzi, YM Zheng, C Carlin, JS Bednash, ... Biorxiv, 2023 | 29 | 2023 |
| Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 BA. 2.86 and FLip variants P Qu, K Xu, JN Faraone, N Goodarzi, YM Zheng, C Carlin, JS Bednash, ... Cell 187 (3), 585-595. e6, 2024 | 27 | 2024 |
| Neutralization of the SARS-CoV-2 deltacron and BA. 3 variants JP Evans, P Qu, C Zeng, YM Zheng, C Carlin, JS Bednash, G Lozanski, ... New England Journal of Medicine 386 (24), 2340-2342, 2022 | 26 | 2022 |
| A new class of broadly neutralizing antibodies that target the glycan loop of Zika virus envelope protein P Qu, C Zhang, M Li, W Ma, P Xiong, Q Liu, G Zou, D Lavillette, F Yin, ... Cell discovery 6 (1), 5, 2020 | 24 | 2020 |
| Yeast-produced subunit protein vaccine elicits broadly neutralizing antibodies that protect mice against Zika virus lethal infection W Zhang, P Qu, D Li, C Zhang, Q Liu, G Zou, M Dupont-Rouzeyrol, ... Antiviral Research 170, 104578, 2019 | 18 | 2019 |
